KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biogen (BIIB) Change in Acquisitions & Divestments (2016 - 2025)

Historic Change in Acquisitions & Divestments for Biogen (BIIB) over the last 17 years, with Q4 2025 value amounting to -$33.6 million.

  • Biogen's Change in Acquisitions & Divestments rose 6525.34% to -$33.6 million in Q4 2025 from the same period last year, while for Dec 2025 it was $23.0 million, marking a year-over-year change of. This contributed to the annual value of $23.0 million for FY2025, which is N/A changed from last year.
  • Biogen's Change in Acquisitions & Divestments amounted to -$33.6 million in Q4 2025, which was up 6525.34% from $56.6 million recorded in Q3 2025.
  • In the past 5 years, Biogen's Change in Acquisitions & Divestments registered a high of $5.7 billion during Q3 2023, and its lowest value of -$96.7 million during Q4 2024.
  • Moreover, its 5-year median value for Change in Acquisitions & Divestments was $566.3 million (2022), whereas its average is $851.8 million.
  • Its Change in Acquisitions & Divestments has fluctuated over the past 5 years, first skyrocketed by 24679.89% in 2023, then tumbled by 9985.1% in 2024.
  • Over the past 5 years, Biogen's Change in Acquisitions & Divestments (Quarter) stood at $1.4 billion in 2021, then tumbled by 58.88% to $566.3 million in 2022, then soared by 906.29% to $5.7 billion in 2023, then plummeted by 101.7% to -$96.7 million in 2024, then soared by 65.25% to -$33.6 million in 2025.
  • Its last three reported values are -$33.6 million in Q4 2025, $56.6 million for Q3 2025, and -$96.7 million during Q4 2024.